National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

Oncaspar-IV (ON-kah-spar …)

 A drug used to treat acute lymphoblastic leukemia (ALL). It is a form of the anticancer drug PEG-asparaginase that stays in the body longer. Oncaspar-IV is an enzyme that breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. It is a type of protein synthesis inhibitor. Also called EZN-2285 and SC-PEG E. coli L-asparaginase.



Previous Definitions:omentum, omeprazole, Ommaya reservoir, ON 01910.Na, Oncaspar
Next Definitions:oncogene, oncologist, oncology, oncology nurse, oncology pharmacy specialist

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov